|
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II |
14/06/2018 |
BIOCEN |
|
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. |
15/08/2018 |
BIOCEN |
|
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
17/02/2017 |
BIOCEN |
|
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
14/08/2017 |
BIOCEN |
|
Combifer-T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women. |
14/01/2019 |
BIOCEN |
|
BIOMODULINA T in a long-lived population at high risk of COVID-19 infection |
19/09/2020 |
BIOCEN |
|
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study |
21/12/2020 |
BIOCEN |
|
Tisuacryl® in Dental Hyperesthesia |
2008-09-18 |
BIOMAT |
|
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
24/04/2023 |
CBQ |
|
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV |
2011-04-18 |
CENSA |
|
SURFACEN in ARDS. Adults. Phase IV |
24/06/2015 |
CENSA |
|
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
29/09/2017 |
CENSA |
|
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold |
2011-11-22 |
CIDEM |
|
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
2013-02-08 |
CIGB |
|
MAGINC Study |
2011-07-12 |
CIGB |
|
HeberproGen Study |
2011-05-20 |
CIGB |
|
TS-FARMEV Study |
2011-05-16 |
CIGB |
|
AntiCEA M3-I |
2010-12-20 |
CIGB |
|
CIGB-128 administration to patients with surgically-treated keloids. |
2010-12-24 |
CIGB |
|
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
2010-12-27 |
CIGB |
